- Products
- Supply Chain Solutions
- Custom Synthesis
- Facilities
- About us
- Investor
- Annual Reports
- Annual Returns
- Disclosures under Regulation 46 of SEBI (LODR) Regulations
- Code of Conduct insider Trading
- Whistle Blower Policy
- Code of fair disclosure
- Corporate Governance
- Corporate Information
- Prospectus
- Grievance Cell
- Shareholding Pattern
- Vigil Machanism
- AGM & Compliances
- Quarterly/Half Yearly Results
- Notices
- Policies
- Encumbrance by Promotors
- Regulation 30
- CSR
-
Product Finder
- OR
Febuxostat
Uses:
Febuxostat is in a class of medications called xanthine oxidase inhibitors. It works by decreasing the amount of uric acid that is made in the body. Febuxostat is used to prevent gout.
Identifiers
- CAS No:
- [144060-53-7]
- BRN No:
- -
- UN No:
- -
Properties
- Molecular Formula:
- C16H16N2O3S
- Molecular Weight:
- 316.37 g/mol
Specifications
Sr. No. | Test | Limits |
---|---|---|
1 | Description | Off –white to pale yellow powder. |
2 | Solubility | Soluble in Tetrahydrofuran, and in Ethanol |
3 | Identification | |
a) By FTIR | The Infrared absorption spectrum of the sample should be concordant with that of the standard. | |
b) By HPLC | The retention time of the principal peak in sample preparation should correspond with that obtained in standard preparation. | |
4 | Water Content by KF (%, w/w) | Not more than 1.0 |
5 | Sulphated Ash (%, w/w) | Not more than 0.1 |
6 | Heavy Metals (ppm) | Not more than 20 |
7 | Related Substances by HPLC (%, w/w) Single maximum impurity Total impurities | Not more than 0.5 Not more than 1.0 |
8 | Assay by HPLC(%, w/w)
(As |
Between 98.0 to 102.0 |